Bod Australia Ltd ( (AU:BOD) ) just unveiled an update.
Bod Science Limited has announced a change in its company secretary, with Carlie Hodges resigning and Joanne Patterson being appointed as her replacement. This change occurs as the company continues to operate under a Deed of Company Arrangement, reflecting ongoing restructuring efforts. The appointment of a new company secretary may impact the company’s administrative operations and stakeholder relations as it navigates its current financial and strategic challenges.
More about Bod Australia Ltd
Bod Science Limited is a company focused on cannabis drug development and product innovation. It aims to advance research and development through clinical trials to commercialize scientifically proven products for patients and consumers. The company collaborates with large corporate entities and leading research organizations to further the use of cannabis-related medicines with therapeutic benefits.
YTD Price Performance: 20.0%
Technical Sentiment Signal: Buy
Current Market Cap: A$4.26M
For an in-depth examination of BOD stock, go to TipRanks’ Stock Analysis page.